ERG/VEP

RetEval

Revolutionary ERG/VEP Anywhere for Anyone
Introducing the first objective tool to measure diabetic retinopathy progression risk like no other. The rapid and non-invasive RETeval ® Device combines retina cell stress with pupil light response. This powerful combination provides a superior progression risk assessment. Measure all your diabetic retinopathy patients with the DR assessment every visit to determine their risk of progression. Superior predictive power compared to the current Standard of Care (ETDRS stereo photography).